In chronic myeloid leukemia (CML), SNHG5 regulates the proliferation, differentiation, and apoptosis of leukemia cells by inhibiting methylation of the death receptor 4 (DR4) gene (67). Here, TNFRSF10A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.